Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19
暂无分享,去创建一个
D. Mutter | E. Andrès | H. Merdji | F. Meziani | T. Baumert | S. Tripon | M. Doffoel | N. Lefèbvre | T. Fabacher | E. Schmitt | P. Bilbault | J. Muller | S. Lescuyer | Sabrina Garnier-Kepka | P. Borgne | Frédéric Chaffraix | F. Chaffraix